Amanda Walker

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Amanda Walker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Radiotherapy Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
cancer Physics & Astronomy
Hodgkin Disease Medicine & Life Sciences
Radiation Oncology Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
radiation therapy Physics & Astronomy

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

Clinical development of novel drug–radiotherapy combinations

Ahmad, S. S., Crittenden, M. R., Tran, P. T., Kluetz, P. G., Blumenthal, G. M., Bulbeck, H., Baird, R. D., Williams, K. J., Illidge, T., Hahn, S. M., Lawrence, T. S., Spears, P. A., Walker, A. & Sharma, R. A., Mar 1 2019, In : Clinical Cancer Research. 25, 5, p. 1455-1461 7 p.

Research output: Contribution to journalReview article

Religious Philosophies
Organ Preservation
Patient Advocacy

U.S. Food and drug administration approval: Neratinib for the extended adjuvant treatment of early-stage HER2-positive breast cancer

Singh, H., Walker, A., Amiri-Kordestani, L., Cheng, J., Tang, S., Balcazar, P., Barnett-Ringgold, K., Palmby, T. R., Cao, X., Zheng, N., Liu, Q., Yu, J., Pierce, W. F., Daniels, S. R., Sridhara, R., Ibrahim, A., Kluetz, P. G., Blumenthal, G. M., Beaver, J. & Pazdur, R., Aug 1 2018, In : Clinical Cancer Research. 24, 15, p. 3486-3491 6 p.

Research output: Contribution to journalArticle

Drug Approval
Breast Neoplasms

Clinical Development of Cancer Drugs in Combination With External Beam Radiation Therapy: US Food and Drug Administration Perspective

Walker, A., Kim, H., Saber, H., Kluetz, P. G., Kim, G. & Pazdur, R., May 1 2017, In : International Journal of Radiation Oncology Biology Physics. 98, 1, p. 5-7 3 p.

Research output: Contribution to journalEditorial

Drug Combinations
United States Food and Drug Administration
radiation therapy

Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Citrin, D. E., Prasanna, P. G. S., Walker, A., Freeman, M. L., Eke, I., Barcellos-Hoff, M. H., Arankalayil, M. J., Cohen, E. P., Wilkins, R. C., Ahmed, M. M., Anscher, M. S., Movsas, B., Buchsbaum, J. C., Mendonca, M. S., Wynn, T. A. & Coleman, C. N., Jul 1 2017, In : Radiation research. 188, 1, p. 1-20 20 p.

Research output: Contribution to journalReview article

Radiation Pneumonitis
National Cancer Institute (U.S.)

FDA approval of palbociclib in combination with fulvestrant for the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer

Walker, A., Wedam, S., Amiri-Kordestani, L., Bloomquist, E., Tang, S., Sridhara, R., Chen, W., Palmby, T. R., Zirkelbach, J. F., Fu, W., Liu, Q., Tilley, A., Kim, G., Kluetz, P. G., McKee, A. E. & Pazdur, R., Oct 15 2016, In : Clinical Cancer Research. 22, 20, p. 4968-4972 5 p.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Disease-Free Survival